IVERMECTIN 3 MG TABLET
Product Description
Humanis Saglik A.S.
-
Country/Region:Türkiye
-
On CPHI since:2020
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
Categories
Humanis Saglik A.S.
-
Country/Region:Türkiye
-
On CPHI since:2020
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
More Products from Humanis Saglik A.S. (36)
-
Product EMPAGLIFLOZIN FCT 10 MG & 25 MG
EMPAGLIFLOZIN FCT 10 MG & 25 MG -
Product TADALAFIL + MACITENTAN FCT 40 mg + 10 mg
TADALAFIL + MACITENTAN FCT 40 mg + 10 mg -
Product DOLUTEGRAVIR 50 mg FCT
DOLUTEGRAVIR 50 mg FCT -
Product TENOFOVIR ALAFENAMIDE FCT 25 MG
TENOFOVIR ALAFENAMIDE FCT 25 MG -
Product IVERMECTIN CREAM 0,01
15 gr, 30 gr, 45 gr Tube -
Product RIOCIGUAT TABLET 0.5 mg, 1 mg, 1.5 mg, 2 mg, 2.5 mg
42, 84, 90, 294 Tablets -
Product EDOXABAN FCT 15 mg & 30 mg & 60 mg
EDOXABAN FCT 15 mg & 30 mg & 60 mg -
Product PERAMPANEL FCT 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg
PERAMPANEL FCT 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg -
Product EMPAGLIFLOZIN + LINAGLIPTIN FCT 10 mg + 5 mg, 25 mg + 5 mg
EMPAGLIFLOZIN + LINAGLIPTIN FCT 10 mg + 5 mg, 25 mg + 5 mg -
Product MACITENTAN 10 MG FCT
28 Tablets -
Product SACUBITRIL + VALSARTAN 24 mg + 26 mg, 49 mg + 51 mg, 97 mg + 103 mg
SACUBITRIL + VALSARTAN 24 mg + 26 mg, 49 mg + 51 mg, 97 mg + 103 mg
Humanis Saglik A.S. resources (4)
-
News Turquality
Humanis joins the TURQUALITY Programme -
Video Humanis Introduction
Humanis operates on a human-oriented basis and offers the basic means for healthier living for all. We rely on our innovative powers and agile pharmaceuticals and health products manufacturing capabilities to substantiate our genuine steps toward shaping the future for better health and wellbeing. We materialize innovative ideas around our values, and pledge better health and wellbeing services wherever there are humans. We aim to grow as a global actor and bring the good around the world by advancing our pharmaceuticals and health products manufacturing capabilities based on technology. We make a difference with our R&D center, and export our products to 50+ countries. We conduct indoor manufacturing operations in a 45.000 sqm area and have a potential utility space of 108.000 sqm, generating up to 330 million units a year.
-
News EU-GMP
We successfully completed the EU GMP (European Union Good Manufacturing Practices) audit conducted by the Belgian authorities. -
News Humanis, the Rising Star of the Pharmaceutical Industry, Expands into China
Humanis, manufacturing to European Union standards, becomes the first Turkish company to export pharmaceuticals to China











